hEGF-dependent formation of hemoblobinized CFUe from EE-T-Y343 and EE-T-Y343F transgenic mice
| Receptor form (mouse no.) . | hEGF-dependent CFUe/ CFUe formed in EPO (%) . |
|---|---|
| EE-T-Y343F (64) | 33 |
| EE-T-Y343F (76) | 43 |
| EE-T-Y343F (59) | 60 |
| EE-T-Y343F (83) | 22 |
| EE-T-Y343F (62) | 9 |
| EE-T-Y343F (mean ± SE, n = 5) | 33 ± 9 |
| EE-T-Y343 (mean ± SE, n = 5) | 110 ± 21 |
| Receptor form (mouse no.) . | hEGF-dependent CFUe/ CFUe formed in EPO (%) . |
|---|---|
| EE-T-Y343F (64) | 33 |
| EE-T-Y343F (76) | 43 |
| EE-T-Y343F (59) | 60 |
| EE-T-Y343F (83) | 22 |
| EE-T-Y343F (62) | 9 |
| EE-T-Y343F (mean ± SE, n = 5) | 33 ± 9 |
| EE-T-Y343 (mean ± SE, n = 5) | 110 ± 21 |